These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7401511)

  • 1. [Phenotyping of the hyperlipoproteinemia in arteriosclerosis obliterans of the lower extremities].
    Il'chuk OS; Pokrasen NM
    Klin Khir (1962); 1980 Jul; (7):51-3. PubMed ID: 7401511
    [No Abstract]   [Full Text] [Related]  

  • 2. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Parakhoniak NV; Zubova TA
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid metabolism indices of patients with arteriosclerosis obliterans of the lower extremities].
    Satmari VV; Kucher VN; Portugal' AS; Gribenko VV
    Vrach Delo; 1984 Feb; (2):70-1. PubMed ID: 6719877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical importance of the regional study of blood serum lipids in arteriosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Kontorshchikova KN; Parakhoniak NV
    Patol Fiziol Eksp Ter; 1986; (2):23-5. PubMed ID: 3714313
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of hemosorption on the lipid and lipoprotein composition of the blood plasma].
    Perepelitsa VN
    Vrach Delo; 1990 Jun; (6):32-4. PubMed ID: 2399714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dynamics of the lipid metabolic shifts during the naphthalan therapy of patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Gulieva SA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1992; (3):61-3. PubMed ID: 1413616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipoproteins in arteriosclerosis obliterans of the lower limbs].
    Sznajderman M; Rymaszewski Z; Kancelarczyk WL; Kuczyńska K
    Pol Arch Med Wewn; 1983 Sep; 70(3):125-30. PubMed ID: 6657491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Concentration of lipids in the skin, arterial wall and blood of patients with arteriosclerosis obliterans of the vessels of the lower extremities].
    Nikitin IuP; Gordienko IA; Dolgov AV; Safonov VA
    Ter Arkh; 1987; 59(1):34-7. PubMed ID: 3563912
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 11. [The lipid composition of the blood plasma in patients with ischemic heart disease and concomitant arteriosclerosis obliterans of the arteries of the lower extremities].
    Iastrebov GN; Volkov VS; Bel'chenko DI
    Ter Arkh; 1992; 64(9):61-4. PubMed ID: 1481157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of dyslipoproteinemia on long-term results of surgical treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Sedov VM; Mirchuk KK; Lebedev LV
    Vestn Khir Im I I Grek; 2004; 163(2):50-5. PubMed ID: 15199771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the correlation between impedance rheography data, function tests and basic laboratory studies in patients with arteriosclerosis obliterans of the lower extremities].
    Lukjan H; Dabrowski S; Bielawiec M
    Kardiol Pol; 1985; 28(12):776-83. PubMed ID: 3835378
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipids and lipoproteins in arteriosclerosis obliterans of the lower extremities.
    Berezovsky LA; de Wolfe VG; Lewis LA
    Medicina (B Aires); 1978; 38(6 Pt 1):652-8. PubMed ID: 750857
    [No Abstract]   [Full Text] [Related]  

  • 15. [HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
    Zák A; Zapletalová J; Puchmayer V; Tvrzická E; Skorepa J
    Cas Lek Cesk; 1981 Feb; 120(7):189-93. PubMed ID: 7226186
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of complex treatment on indicators of lipid metabolism in patients with arteriosclerosis obliterans].
    Polous IuM; Loĭko IK; Kurko VS; Gribenko GP; Golomazov MF
    Vrach Delo; 1986 Jun; (6):4-7. PubMed ID: 3750955
    [No Abstract]   [Full Text] [Related]  

  • 17. [Initial experiences with the effect of chronic intermittent electromyostimulation in patients with hyperlipoproteinemias and arterial circulatory disorders].
    Kuklinski B; Gibas P; Köhler H; Grossmann KD; Rühlmann C; Zimmermann R; Voigt H; Reuter W; Duck HJ; Bühnert G
    Z Gesamte Inn Med; 1988 Jan; 43(1):6-11. PubMed ID: 3258458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
    Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
    Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
    [No Abstract]   [Full Text] [Related]  

  • 19. [State of the blood kallikrein-kinin system in arteriosclerosis obliterans of the lower extremities].
    Kobets LG; Pokrasen NM
    Klin Khir (1962); 1980 Jul; (7):75-6. PubMed ID: 6901914
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential diagnosis of arteriosclerosis obliterans and thromboangiitis obliterans].
    Emmrich R
    Z Gesamte Inn Med; 1973 Jul; 28(13):389-94. PubMed ID: 4804902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.